Neonc Technologies Holdings, Inc. SEC filings NTHI
Neonc Technologies Holdings, Inc. has 208 filings in SEC EDGAR's recent list, going back to Jun 22, 2023. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Jun 25, 2026 | — |
| EFFECT | Filing | Jun 23, 2026 | — |
| EFFECT | Filing | Apr 16, 2026 | — |
| CORRESP | Letter to the SEC | Apr 14, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2026 | — |
| EFFECT | Filing | Apr 9, 2026 | — |
| CORRESP | Letter to the SEC | Apr 7, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2026 | — |
| EFFECT | Filing | Feb 12, 2026 | — |
| CORRESP | Letter to the SEC | Feb 10, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2026 | — |
| D | Filing | Feb 9, 2026 | — |
| EFFECT | Filing | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| D | Filing | Dec 18, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2025 | — |
| NT 10-Q | Filing | Aug 14, 2025 | Jun 30, 2025 |
| EFFECT | Filing | Jun 16, 2025 | — |
| CORRESP | Letter to the SEC | Jun 12, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2025 | — |
| EFFECT | Filing | May 6, 2025 | — |
| CORRESP | Letter to the SEC | May 2, 2025 | — |
| UPLOAD | Letter from the SEC | May 2, 2025 | — |
| D | Filing | Apr 11, 2025 | — |
| CERT | Filing | Mar 26, 2025 | — |
| EFFECT | Filing | Mar 25, 2025 | — |
| 8-A12B | Filing | Mar 24, 2025 | — |
| D | Filing | Mar 24, 2025 | — |
| CORRESP | Letter to the SEC | Mar 21, 2025 | — |
| CORRESP | Letter to the SEC | Feb 26, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2025 | — |
| CORRESP | Letter to the SEC | Jan 30, 2025 | — |
| CORRESP | Letter to the SEC | Jan 2, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2024 | — |
| DRS/A | Filing | Dec 10, 2024 | — |
| CORRESP | Letter to the SEC | Dec 9, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2024 | — |
| DRS | Filing | Oct 29, 2024 | — |
| D | Filing | Oct 28, 2024 | — |
| RW | Filing | Jun 12, 2024 | — |
| DRS/A | Filing | Sep 27, 2023 | — |
| DRS/A | Filing | Aug 9, 2023 | — |
| D | Filing | Jul 5, 2023 | — |
| DRS | Filing | Jun 22, 2023 | — |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NTHI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Calabasas, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1979414
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.